Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan Ashworth currently holds 59,000 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Ashworth has been a net neutral trader of CTMX stock. They have purchased $0 and sold $0 worth of shares.
Alan Ashworth's most recent insider trade was on Jun 17, 2026, when they sold 59,000 shares at $0.00 per share.
Alan Ashworth serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Alan Ashworth holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Alan Ashworth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Alan Ashworth was on Jun 17, 2026, when they purchased $0 worth of CTMX shares. This transaction involved 59,000 shares at N/A per share.
Alan Ashworth currently owns 59,000 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan Ashworth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan Ashworth has 2 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for Alan Ashworth and 40,000+ other insiders.